SynAct Pharma (STO: SYNACT)

Last close As at 20/03/2026

SEK16.88

−0.62 (−3.54%)

Market capitalisation

SEK934m

SynAct Pharma is a clinical-stage biotechnology company focussed on the development of treatments to resolve, rather than inhibit, ongoing inflammatory processes in acute and chronic diseases.

Latest Insights

View More

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Jeppe Øvlesen

    CEO

  • Ann Kristin Led

    CFO